Shicheng Guo

Shicheng Guo

@shihcheng.bsky.social

Senior Director, Translational Genetics and Data Science, Translational Medicine | Data Science | Computational Biology | Drug Discovery. Opinions are my own! Linkedin: https://www.linkedin.com/in/shg047/

1.9K followers184 following7.9K posts

Pinned

We are seeking for a 𝗦𝗲𝗻𝗶𝗼𝗿 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁 (𝗧𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗚𝗲𝗻𝗲𝘁𝗶𝗰𝘀 & 𝗥𝗲𝗮𝗹-𝗪𝗼𝗿𝗹𝗱 𝗘𝘃𝗶𝗱𝗲𝗻𝗰𝗲) at 𝗔𝗿𝗿𝗼𝘄𝗵𝗲𝗮𝗱 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀, our 𝗧𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗚𝗲𝗻𝗲𝘁𝗶𝗰𝘀 & 𝗗𝗮𝘁𝗮 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 team. www.linkedin.com/posts/shg047...

Nearly 3,000 abstracts from ACR Convergence 2026 are now online! A rich resource for exploring emerging targets, disease mechanisms, and clinical advances in rheumatology ahead of the November 6–11 meeting in Orlando. #ACR26 #Rheumatology

Discover FLOWR.ROOT: a model merging 3D ligand creation and binding predictions (pIC50, pKi, pKd, pEC50) with high-confidence estimation in one. Fascinating, right? PMID:42409794, Nat Commun 2026, @NatureComms https://doi.org/10.1038/s41467-026-74130-9 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪

doi.orgFLOWR.ROOT – A flow matching-based foundation model for joint multi-purpose structure-aware 3D ligand generation and affinity prediction | Nature CommunicationsWe present FLOWR.ROOT, an SE(3)-equivariant flow-matching foundation model that unifies pocket-aware 3D ligand generation with multi-endpoint binding affinity prediction (pIC50, pKi, pKd, pEC50) and pLDDT-based confidence estimation in a single backbone. One trained model supports de novo pocket-conditional generation, interaction- and pharmacophore-conditional sampling, scaffold hopping and elaboration, and fragment growing or replacement, enabled by a mixed isotropic–anisotropic prior placement strategy. Training proceeds in three stages: large-scale pre-training on billions of ligand conformations and millions of mixed-fidelity protein–ligand complexes, refinement on curated co-crystal data, and project-specific adaptation via parameter-efficient LoRA finetuning. Joint structure–affinity modelling enables inference-time importance-sampling guidance for single- and multi-objective design without external scoring functions. Case studies on kinase selectivity (CK2α/CLK3) and scaffold e

New research reveals that parvalbumin-expressing (BF-PV) inhibitory neurons in the basal forebrain enhance sustained attention, challenging traditional views on cholinergic roles in focus! PMID:42349384, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S009286742600646X #Medsky #Pharmsky #RNA 🧪

cell.comA disinhibitory basal forebrain-to-cortex projection supports sustained attentionCell Press article: A disinhibitory basal forebrain-to-cortex projection supports sustained attention

New study: Integrin-α8⁺ mesenchymal stem cells in the bone marrow play key roles in maintaining hematopoietic stem cell function. Depleting these cells decreases HSC numbers and activity. PMID:42409817, Nat Commun 2026, @NatureComms https://doi.org/10.1038/s41467-026-75276-2 #Medsky #Pharmsky #RNA 🧪

doi.orgEndosteal integrin-α8⁺ mesenchymal stem cells maintain haematopoietic stem cell function via extracellular matrix-mediated interactions | Nature CommunicationsThe stem cell niche is a specialised microenvironment essential for maintaining haematopoietic stem cells (HSCs). Here we identify a distinct subset of mesenchymal stem cells (MSCs) expressing integrin α8 (Itga8⁺ MSCs) within the bone marrow (BM) endosteum. These cells exhibit distinct MSC properties and higher haematopoietic supportive activity than other MSC subsets. Depletion of Itga8⁺ MSCs decreased HSC numbers, reduced quiescence of endosteal HSCs and diminished BM repopulating capacity. Itga8⁺ MSCs support haematopoiesis through cell adhesion-related mechanisms. Single-cell RNA sequencing further identified Itga8⁺ MSCs as a distinct subpopulation within bone-lining cells. Moreover, we identified Mfap4 as a candidate factor expressed in Itga8⁺ MSCs, and Mfap4 supported the BM reconstitution capacity of HSCs. These results suggest that Itga8⁺ MSCs represent a distinct niche cell population for HSC maintenance. This work provides new insights into HSC regulation and strategies to op